SOPHARMA (SPH): Notification - Veta Pharma AD - raport 99
UNI - EN REPORT No99/2016
The Board of Directors of Sopharma AD decided to purchase up to 100% of the capital of “Veta Pharma” AD for a price not exceeding 2.12 BGN per share. The Board authorised the Executive Director to undertake all necessary legal actions thereby.
“Veta Pharma” AD is a modern and dynamic Bulgarian pharmaceutical porducer of 47 different products divided in three categories: medicinal products, food additives and cosmetic products. The volume of sales for 2015 exceeds 3 million packages on the Bulgarian pharmaceutical market. 50 people work at the company.
“Veta Pharma” AD plans, produces and distributes its products in accordance with the Good Manufacturing Practice (GMP) and the standards applied by the Bulgarian and European legal framewok.
